USP seeks comment for proposed revisions to Chapter 797
USP has announced a public comment and review period process forproposed changes to USP General Chapter 797 PharmaceuticalCompounding of Sterile Preparations. The public comment period willend on Aug 15. In addition, USP will host a series of six Webinarsdesigned to provide additional information on the proposedrevisions.
USP seeks comment for proposed revisions to Chapter 797
USP has announced a public comment and review period process for proposed changes to USP General Chapter 797 Pharmaceutical Compounding of Sterile Preparations. The public comment period will end on Aug 15. In addition, USP will host a series of six Webinars designed to provide additional information on the proposed revisions. The proposed changes have been posted on the USP Web site at http://www.usp.org/. Chapter 797 sets practice standards to help ensure that compounded sterile preparations are of the highest quality.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
